Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
Open Access
- 1 November 1996
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 28 (5), 1323-1327
- https://doi.org/10.1016/s0735-1097(96)00301-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinaprilJournal of the American College of Cardiology, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Placebo-Controlled Study of Lisinopril in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1987
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.Circulation, 1984